PREGABALIN ARTIFICIAL HAPTEN AND PREGABALIN ARTIFICIAL ANTIGEN, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF
Disclosed are a pregabalin artificial hapten and a pregabalin artificial antigen, preparation methods therefor, and applications thereof. The molecular structural formula of the pregabalin artificial hapten is as shown in formula (I), and the molecular structural formula of the pregabalin artificial...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SHAO, Yueshui WANG, Zhen |
description | Disclosed are a pregabalin artificial hapten and a pregabalin artificial antigen, preparation methods therefor, and applications thereof. The molecular structural formula of the pregabalin artificial hapten is as shown in formula (I), and the molecular structural formula of the pregabalin artificial antigen is as shown in formula (II). The application is an application of the pregabalin artificial antigen in the preparation of an anti-pregabalin antibody. The pregabalin artificial hapten retains the feature structure of pregabalin to the greatest extent, has an active group that can be conjugated to a carrier protein, and thus can be used as an antigenic determinant. The further prepared pregabalin artificial antigen can be immunize to obtain an anti-pregabalin antibody having high affinity, high sensitivity and strong specificity, the titer of immune serum obtained by immunizing New Zealand white rabbits is as high as 1:90000, and the anti-pregabalin antibody can be used for rapid and accurate immunoassay an |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022188302A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022188302A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022188302A13</originalsourceid><addsrcrecordid>eNqNjLEKwjAURbs4iPoPAdcKbbp0faYvzYOYhPigYykSJ9FCxe9XS0cHpwvnHO46e4WILRzBkhMQmTQpAisMBMYPcY34HYBjatHlXx0gApN34oRsfHMWbDCi9jGfDyAES2ouFuX1Nltdh9uUdstusr1GVuaQxkefpnG4pHt69p2XhZRlXVeFhLL6r3oD7BE6Lw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PREGABALIN ARTIFICIAL HAPTEN AND PREGABALIN ARTIFICIAL ANTIGEN, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF</title><source>esp@cenet</source><creator>SHAO, Yueshui ; WANG, Zhen</creator><creatorcontrib>SHAO, Yueshui ; WANG, Zhen</creatorcontrib><description>Disclosed are a pregabalin artificial hapten and a pregabalin artificial antigen, preparation methods therefor, and applications thereof. The molecular structural formula of the pregabalin artificial hapten is as shown in formula (I), and the molecular structural formula of the pregabalin artificial antigen is as shown in formula (II). The application is an application of the pregabalin artificial antigen in the preparation of an anti-pregabalin antibody. The pregabalin artificial hapten retains the feature structure of pregabalin to the greatest extent, has an active group that can be conjugated to a carrier protein, and thus can be used as an antigenic determinant. The further prepared pregabalin artificial antigen can be immunize to obtain an anti-pregabalin antibody having high affinity, high sensitivity and strong specificity, the titer of immune serum obtained by immunizing New Zealand white rabbits is as high as 1:90000, and the anti-pregabalin antibody can be used for rapid and accurate immunoassay an</description><language>chi ; eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220915&DB=EPODOC&CC=WO&NR=2022188302A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220915&DB=EPODOC&CC=WO&NR=2022188302A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHAO, Yueshui</creatorcontrib><creatorcontrib>WANG, Zhen</creatorcontrib><title>PREGABALIN ARTIFICIAL HAPTEN AND PREGABALIN ARTIFICIAL ANTIGEN, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF</title><description>Disclosed are a pregabalin artificial hapten and a pregabalin artificial antigen, preparation methods therefor, and applications thereof. The molecular structural formula of the pregabalin artificial hapten is as shown in formula (I), and the molecular structural formula of the pregabalin artificial antigen is as shown in formula (II). The application is an application of the pregabalin artificial antigen in the preparation of an anti-pregabalin antibody. The pregabalin artificial hapten retains the feature structure of pregabalin to the greatest extent, has an active group that can be conjugated to a carrier protein, and thus can be used as an antigenic determinant. The further prepared pregabalin artificial antigen can be immunize to obtain an anti-pregabalin antibody having high affinity, high sensitivity and strong specificity, the titer of immune serum obtained by immunizing New Zealand white rabbits is as high as 1:90000, and the anti-pregabalin antibody can be used for rapid and accurate immunoassay an</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAURbs4iPoPAdcKbbp0faYvzYOYhPigYykSJ9FCxe9XS0cHpwvnHO46e4WILRzBkhMQmTQpAisMBMYPcY34HYBjatHlXx0gApN34oRsfHMWbDCi9jGfDyAES2ouFuX1Nltdh9uUdstusr1GVuaQxkefpnG4pHt69p2XhZRlXVeFhLL6r3oD7BE6Lw</recordid><startdate>20220915</startdate><enddate>20220915</enddate><creator>SHAO, Yueshui</creator><creator>WANG, Zhen</creator><scope>EVB</scope></search><sort><creationdate>20220915</creationdate><title>PREGABALIN ARTIFICIAL HAPTEN AND PREGABALIN ARTIFICIAL ANTIGEN, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF</title><author>SHAO, Yueshui ; WANG, Zhen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022188302A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2022</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SHAO, Yueshui</creatorcontrib><creatorcontrib>WANG, Zhen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHAO, Yueshui</au><au>WANG, Zhen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PREGABALIN ARTIFICIAL HAPTEN AND PREGABALIN ARTIFICIAL ANTIGEN, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF</title><date>2022-09-15</date><risdate>2022</risdate><abstract>Disclosed are a pregabalin artificial hapten and a pregabalin artificial antigen, preparation methods therefor, and applications thereof. The molecular structural formula of the pregabalin artificial hapten is as shown in formula (I), and the molecular structural formula of the pregabalin artificial antigen is as shown in formula (II). The application is an application of the pregabalin artificial antigen in the preparation of an anti-pregabalin antibody. The pregabalin artificial hapten retains the feature structure of pregabalin to the greatest extent, has an active group that can be conjugated to a carrier protein, and thus can be used as an antigenic determinant. The further prepared pregabalin artificial antigen can be immunize to obtain an anti-pregabalin antibody having high affinity, high sensitivity and strong specificity, the titer of immune serum obtained by immunizing New Zealand white rabbits is as high as 1:90000, and the anti-pregabalin antibody can be used for rapid and accurate immunoassay an</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng ; fre |
recordid | cdi_epo_espacenet_WO2022188302A1 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS TESTING |
title | PREGABALIN ARTIFICIAL HAPTEN AND PREGABALIN ARTIFICIAL ANTIGEN, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A53%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHAO,%20Yueshui&rft.date=2022-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022188302A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |